JPS58126798A - Novel method for determination of unsaturated fatty acid - Google Patents

Novel method for determination of unsaturated fatty acid

Info

Publication number
JPS58126798A
JPS58126798A JP839082A JP839082A JPS58126798A JP S58126798 A JPS58126798 A JP S58126798A JP 839082 A JP839082 A JP 839082A JP 839082 A JP839082 A JP 839082A JP S58126798 A JPS58126798 A JP S58126798A
Authority
JP
Japan
Prior art keywords
unsaturated fatty
acid
fatty acid
fatty acids
test solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP839082A
Other languages
Japanese (ja)
Inventor
Hideo Misaki
美崎 英生
Shigeyuki Imamura
茂行 今村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP839082A priority Critical patent/JPS58126798A/en
Priority to FR8300685A priority patent/FR2520006B1/en
Priority to DE19833301655 priority patent/DE3301655A1/en
Publication of JPS58126798A publication Critical patent/JPS58126798A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/61Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To determine an unsaturated fatty acid liberated in measuring the lipase activity with the unsaturated fatty acid, particularly glyceride of the unsaturated fatty acid, as a substrate easily and accurately, by using lipoxygenase and peroxidase. CONSTITUTION:A test solution containing an unsaturated fatty acid, e.g. a test solution, containing the unsaturated fatty acid liberated and produced by the lipase activity from a glyceride of the unsaturated fatty acid, is reacted with a lipoxygenase in the presence of oxygen to produce a peroxide of the unsaturated fatty acid, which is then reacted with peroxidase and a hydrogen donor, e.g. an oxidizable compound which is a color reagent capable of producing the visual change in hue by the oxidation. After completing the reaction, the degree of the coloring is measured by the absorbance at a specific absorption wavelength, and the amount of the unsaturated fatty acid in the test solution is calculated and determined from the absorbance.

Description

【発明の詳細な説明】 本発明は新規な不飽和脂肪酸の定1b乙関するもので、
また特に不飽和脂肪酸のクリセフイドを基質とするリパ
ーゼ活性測定tこおける遊離された不飽和脂肪酸の定量
法に有用である。
[Detailed Description of the Invention] The present invention relates to a novel unsaturated fatty acid,
It is also particularly useful for quantifying unsaturated fatty acids liberated in lipase activity measurements using unsaturated fatty acid cricephids as substrates.

リパーゼはグリセフィトを脂肪酸およびグリセリン10
分解する作用を有する酵素で、脂肪酸の炭素鎖が短かい
グリセフィト1こ作用するエステラーゼとは区別されて
いる。このリパーゼは動物組織内1こ広く分布しており
、特&C牌臓分泌液中tこ高濃度である。また絆臓疾患
の場合をこはリパーゼは血液中に流入するためtこ、血
清中リパーゼ活性の測定が絆臓疾患の発見1こ有用であ
る。
Lipase converts glycephyte into fatty acids and glycerin 10
It is an enzyme that has the action of degrading fatty acids, and is distinguished from esterases, which act on glycephyte, which has a short carbon chain of fatty acids. This lipase is widely distributed in animal tissues, and is highly concentrated in the secretion fluid of spleen. Furthermore, in the case of bond disease, lipase flows into the blood, so measuring serum lipase activity is useful for detecting bond disease.

従来の血清中リパーゼ活性測定法としては1例えば被検
液たる血清tc、IJバーゼの基質であるトリグリセラ
イドを過剰tこ加えて作用せしめ、次いでそのリパーゼ
活性1こより遊離された脂肪酸の量をチモールフタレイ
ンなどの指示薬を用いてアルカリ滴定するか、銅塩にて
抽出せしめて測定していたものであった( DeuLs
oh MedizinischWochenschri
fL 、  タo、i’yyo<iり65)、 Ana
lytical Biochemistry、 b +
 ’I j / (/り63 )CIin、Cheto
12/、 /4’69〜/1I73(/り75)〕が、
この測尾においては用いる基質をこより濁りを生ずるた
めをこ透明度による光度計測定は不適当であり、また測
定すべき脂肪酸の量が極めて**で、例えば血清/ w
ll f使用してIO分間反応せしめても遊離される脂
肪酸はわずかo、ooosミリモルであって著しく定量
し難いものであった。また近年、別の血清リパーゼ活性
測定法として、リルン酸のトリグリセフィトを基質とし
、これに血/#ヲ作用させて遊離、生成されたリルン酸
をリボオキシゲナーゼにて酸化せしめ、その酸化反応を
こ消費される酸素の量を酸素電極にて電気的に測定する
方法(C11nical Che −miatry、 
、LZ、 / 63〜/ 65 (/7ざl)〕が報告
されているが、この測定法では酸素電極による酸素の消
費量の定量を行なうためtこ酸素!極の検知のための安
定性や感度をこ著しく影響を受ける欠点があり、またト
リグリセフィトを基質とするために濁りを生ずるために
光度計測定としても不適当であった。
As a conventional method for measuring lipase activity in serum, for example, an excess of triglyceride, which is a substrate for IJbase, is added to serum tc as a test solution and allowed to act, and then the amount of fatty acids liberated from the lipase activity is measured using a thymol cap. It was measured by alkaline titration using an indicator such as rhein or by extraction with copper salt (DeuLs).
oh MedizinischWochenschri
fL, Tao, i'yyo<iri65), Ana
Lytical Biochemistry, b +
'I j / (/ri63) CIin, Cheto
12/, /4'69~/1I73 (/ri75)] is,
In this tail measurement, the substrate used causes turbidity, so photometer measurements based on transparency are inappropriate, and the amount of fatty acids to be measured is extremely high, such as serum/w.
Even if the reaction was carried out for 10 minutes using llf, the amount of fatty acids liberated was only 0,000 millimoles, which was extremely difficult to quantify. In addition, in recent years, another method for measuring serum lipase activity has been developed, in which triglycephyte of lylunic acid is used as a substrate, and the lylunic acid released and produced by the interaction with blood is oxidized with ribooxygenase, and the oxidation reaction is consumed. A method of electrically measuring the amount of oxygen produced using an oxygen electrode (C11nical Che-mitry,
, LZ, /63~/65 (/7 times)], but in this measurement method, the amount of oxygen consumed by the oxygen electrode is determined, so the amount of oxygen! It has the disadvantage that the stability and sensitivity for polar detection are significantly affected, and it is also unsuitable for photometric measurements because it produces turbidity due to the use of triglycephyte as a substrate.

本発明者らは、リパーゼ活性測定に関して種々研究した
結果、不飽和脂肪酸のモノグリセフィト、ジグリセライ
ドまたはトリグリセライドを基質として用い、被検液中
のリパーゼ活性1こより基質から不飽和脂肪酸を遊離せ
しめ、この不飽和脂肪酸を酸素の存在下でリボオキシゲ
ナーゼtごて不飽和脂肪酸の過酸化物となし、この過酸
化物にペルオキシダーゼおよび水素供与体を作用せしめ
ることにより反応系tこおける用いる水素供与体に基く
特異的な分光光学的変化として正確かつ簡便tこ定量し
得ることを完成した。
As a result of various studies regarding the measurement of lipase activity, the present inventors used monoglycephyte, diglyceride, or triglyceride of unsaturated fatty acids as a substrate, and released unsaturated fatty acids from the substrate due to the lipase activity in the test solution. In the presence of oxygen, unsaturated fatty acids are converted into peroxides of unsaturated fatty acids using ribooxygenase, and this peroxide is reacted with peroxidase and a hydrogen donor to form a reaction system based on the hydrogen donor used in the reaction system. It has been completed that this can be accurately and easily quantified as a specific spectroscopic optical change.

本発明は上記の知見1こ基いて完成されたもので、不飽
和脂肪酸含有被検液に、酸素の存在下でリボオキシゲナ
ーゼを作用せしめて不飽和脂肪酸の過酸化物となし、こ
れにペルオキシダーゼおよび水素供与体を作用せしめ、
次いで反応系Qこおける検出できる変化を分光光学的手
段にて測定することを特徴とする不飽和脂肪酸の定量法
であって、特tこリパーゼ活性測定tこおける従来の煩
雑な工程を不用とする簡便な測定法として有用である。
The present invention was completed based on the above findings. Ribooxygenase is made to act on a test solution containing unsaturated fatty acids in the presence of oxygen to form peroxides of unsaturated fatty acids, and peroxidase and Let a hydrogen donor act,
A method for quantifying unsaturated fatty acids, which is characterized in that a detectable change in the reaction system Q is then measured by spectroscopic means, and in particular, it does not require the conventional complicated steps for measuring lipase activity. It is useful as a simple measurement method.

さらtこグリセフィトを基質として微量のリパーゼ活性
を測定するに当っても1本発明では反応液の濁りtこよ
る測定の不適性さを生ずることな(、また用いる電極t
こよる影響もな(、さらに短時間にて正Hに分光光学的
手段tこで極めて簡便をこ測定し得る有用な測定法を提
供するものである。
Furthermore, when measuring trace amounts of lipase activity using glycephyte as a substrate, the present invention does not cause unsuitability of measurement due to turbidity of the reaction solution (also, the electrode used
This provides a useful measuring method that allows positive H to be measured very simply using spectroscopic optical means in a short time.

まず本発明tこおける不飽和脂肪酸含有被検液としては
、不飽和脂肪酸を含有するものであればよく、好ましく
はリパーゼ活性測定tこおける不飽和脂肪酸のグリセフ
ィトである基質からリパーゼ活性tこ基いて遊離、生成
した不飽和脂肪酸を含有する被検液が挙られ、通常血清
中リパーゼやリパーゼ試薬溶液なとのリパーゼ活性を有
する溶液の一定量と、一定濃度をこ調整した不飽和脂肪
酸のグリセライド含有基質溶液の一定量を混合し、37
℃近辺にてS分間以上反応せしめてそのリパーゼ活性に
基いて基質から不飽和脂肪酸を遊離せしめた溶液が用い
られる。またこのリパーゼ活性測定−こ用いられる基質
としての不飽和脂肪酸のグリセライドとしては、モノグ
リセライド、ジグリセライド、トリグリセフィトのいず
れでもよ(、好まし(はモノグリセフィトおよびジグリ
セツイドである。またこのグリセフィトにおける不飽和
脂肪酸や不飽和脂肪酸含有被検液の不飽和脂肪酸として
は、好ましくは二重結合が2個以上あるVス型の炭素数
12〜20の不飽和脂肪酸であり、例えば2、’I−ド
デカジエン酸、り、/2−へキサデカジエン酸、リノー
ル酸(シヌータ、ンスー、−/2−オクタデカジエン酸
)、リルン酸(り、/2゜lj−オクタデカトリエン酸
)、乙、り、12−オクタデカトリエン酸、ii、1t
i−エイコザジ工ン酸%j+ ♂、l/−エイコf )
 I) xン酸、♂、ii、i4を一エイコサトリエン
酸、アフキドン酸(j、f、Il、/’I−エイコサテ
トフエン酸)などが挙られる。
First, the unsaturated fatty acid-containing test solution used in the present invention may be any one containing unsaturated fatty acids, and preferably, the unsaturated fatty acid-containing test solution used in the lipase activity measurement can be obtained from a substrate that is glycephyte of unsaturated fatty acids. The test solution is a test solution containing unsaturated fatty acids released and produced by the process, and is usually a fixed amount of a solution with lipase activity such as serum lipase or lipase reagent solution, and a fixed concentration of unsaturated fatty acid glyceride. Mix a certain amount of substrate solution containing 37
A solution is used that is reacted at around 0.degree. C. for more than S minutes to release unsaturated fatty acids from the substrate based on its lipase activity. The unsaturated fatty acid glyceride used as a substrate for lipase activity measurement may be any of monoglyceride, diglyceride, and triglyceride (preferably monoglycephyt and diglycetoid). The unsaturated fatty acids in the test liquid containing unsaturated fatty acids are preferably V-s type unsaturated fatty acids having 12 to 20 carbon atoms and having two or more double bonds, such as 2,'I-dodecadienoic acid, Ri, /2-hexadecadienoic acid, linoleic acid (sinuta, nsou, -/2-octadecadienoic acid), lylunic acid (ri, /2゜lj-octadecatrienoic acid), otsu, ri, 12-octadecadienoic acid trienoic acid, ii, 1t
i-eicozadiconic acid %j+♂, l/-eicof)
I) xonic acid, ♂, ii, i4-mono-eicosatrienoic acid, afchidonic acid (j, f, Il, /'I-eicosatrienoic acid), and the like.

またリボオキシゲナーゼとしては、少な(とも基質とし
てリノール酸7モルおよび酸素1モルからりノーM酸の
過酸化物l七ルを生成せしめる反応を触媒する酵素(E
、 C,/、 /3. /、 /3.Linoleat
e:oxygen oxidoreducLase )
であって、この反応を触謀する酵素であれば、粗製物、
精製物のいずれでもよく、市販品でも、大豆、腕立など
のまめ科植物や大麦、小麦などから単離、採取したもの
であってよい〔八り、Tappel、Food Re5
earch。
In addition, ribooxygenase is an enzyme (E
, C, /, /3. /, /3. Linoleat
e:oxygen oxidoreducLase)
If the enzyme is responsible for this reaction, the crude product,
Any purified product may be used, and it may be a commercially available product, or one isolated and collected from leguminous plants such as soybeans and pushups, barley, wheat, etc. [Yari, Tappel, Food Re5]
earch.

/I、  1011  (/  タ 3; 3  )、
H,TI+eorell、etal。
/I, 1011 (/ta 3; 3),
H, TI+eorel, etal.

AcLaChem、5cand、、 /、 j7/ (
/9!7))。またリボオキシゲナーゼの使用蓋として
は、通常lテスト当り1000単位以上あればよく、好
ましくは1oooo〜5oooo単位程度使用すればよ
い。
AcLaChem, 5cand, /, j7/ (
/9!7)). In addition, as a cap for ribooxygenase, it is usually sufficient to use 1000 units or more per 1 test, preferably about 100 to 5000 units.

さら1こぺlレオキシダーゼとしては、簡便には市販さ
れている西洋ワサビ由来のベルオキンダーゼを用いれば
よ(、通常/テヌト当り/単位以上あればよく、好まし
くは2〜20単位程度使用すればよい。
Furthermore, as the reoxidase, it is convenient to use commercially available horseradish-derived berokindase (normally, it is sufficient to use more than one unit per tenuto, preferably about 2 to 20 units). .

また水素供与体としては、酸化され得る化合物で、酸化
1こより色調の変化を可視にて生ずる呈色試薬や、紫外
線照射により螢光を発する螢光試薬や発色する発光試薬
が用いられる。また呈色試薬としては通常電子受容体と
フェノール系化合物の組合せがよく用いられるもので、
電子受答体としては、例えばグーアミノアンチピリン、
グーアミノ−3−ヒトフジノー5−メルカプト−1,2
゜+−トリアゾール、3−メチル−1−ベンゾチ7ゾリ
ノンヒドフゾン、2−アミノベンゾチアゾールなどが用
いられ、またフェノール系化合物としては、例えばフェ
ノ−lv%P−クロロフェノ−〃、λ、弘−シクロロフ
ェノール、λ、4!−シアロムフェノー/l/、 P−
ヒドロキシ安息香酸ナトリウム、+、6−ジクロロー〇
−クレグール、3.j−ジクロロ−λ−ヒドロキシベン
ゼンスルホン酸ナトリウム、3.j−キシレノール、N
、N−ジエチIv−m −トtレイジン、N、N−ジエ
タノールアm−)々イジン、N−エチル−N−スルホプ
ロピル−m−)ルイジン、N、N−ジメチ〃アニリン、
N、N−ジエチルアニリン、N、N−ジメチル−m−メ
トキシアニリン、3−アセトアミノ−N、N−ジエチル
アニリン、3−メチル−N−エチlレーN−(β−ヒド
ロキンエチル)アニリン、N−エチル−N−(3−メチ
ルフェニル>  %/−レ アセチルエチ\ンジアミンなどが用いられる。また螢光
試薬や発光試薬1こおける発螢光基質としては、公知の
種々のものが挙られ、例えばビス−(λ、11.1.−
ト+)クロロフェノール)オキザレイト、フエ=7レチ
オヒダントイン、ホモバニリン酸lし 、+−ヒドロキシフェニル酢酸、バニリ\アミン、3−
メトキシアニリン、フロレチン酸、ホルデニン、ルミノ
ールモノアニオン、ルシケニン、ワフインなどが挙られ
る。これらの試薬は例示であって何んら本発明の水素匹
与体を限定するものではなく、またこれらの水素供与体
の使用蓋としては、被検液中に含有されている不飽和脂
肪酸またはその不飽和脂肪酸から生ずるその過酸化物t
こ対して決定すればよく1通常不飽和脂肪酸10対して
5倍モル以上を用いるが、適宜使用する被検液の量、被
検液中の不飽和脂肪酸の不飽和結合度や含有量などをこ
より変更せしめればよい。
As the hydrogen donor, there may be used a color reagent that is a compound that can be oxidized and causes a visible change in color tone upon oxidation, a fluorescent reagent that emits fluorescence upon irradiation with ultraviolet light, or a luminescent reagent that develops color. In addition, a combination of an electron acceptor and a phenolic compound is often used as a coloring reagent.
Examples of electron acceptors include guaminoantipyrine,
Guamino-3-human fusino-5-mercapto-1,2
゜+-triazole, 3-methyl-1-benzoti7zolinonehydrofuzone, 2-aminobenzothiazole, etc. are used, and as the phenolic compound, for example, pheno-lv%P-chloropheno-〃, λ, Hiro -cyclophenol, λ, 4! -Sialompheno/l/, P-
Sodium hydroxybenzoate, +,6-dichloro〇-cregur, 3. Sodium j-dichloro-λ-hydroxybenzenesulfonate, 3. j-xylenol, N
, N-diethylv-m-treizine, N,N-diethanolam-)isoidine, N-ethyl-N-sulfopropyl-m-)luidine, N,N-dimethyaniline,
N,N-diethylaniline, N,N-dimethyl-m-methoxyaniline, 3-acetamino-N,N-diethylaniline, 3-methyl-N-ethyl-N-(β-hydroquinethyl)aniline, N -Ethyl-N-(3-methylphenyl>%/-leacetylethiene diamine, etc.).Furthermore, as the fluorescent substrate in the fluorescent reagent or luminescent reagent 1, various known ones can be mentioned, such as −(λ, 11.1.−
+) chlorophenol) oxalate, Fe = 7 rethiohydantoin, homovanillic acid, +-hydroxyphenylacetic acid, vanillin\amine, 3-
Examples include methoxyaniline, phloretic acid, hordenine, luminol monoanion, lucikenin, and waffin. These reagents are illustrative and do not limit the hydrogen donor of the present invention in any way, and these reagents can be used for unsaturated fatty acids or unsaturated fatty acids contained in the test liquid. The peroxide derived from the unsaturated fatty acid
1Usually, 5 times the mole or more is used for 10 unsaturated fatty acids, but the amount of test solution to be used, the degree of unsaturated bonding and content of unsaturated fatty acids in the test solution, etc. should be determined accordingly. All you have to do is change it.

さらに反応に当って、過当な反応媒体、例えばジメチル
グルグル酸−水酸化ナトリウム緩衝液、リン酸Mr#液
、トリス−塊酸緩衝液、ホウ酸M衝液、その他一般tご
用いられている櫨々のHi衝液が用いられるもので、通
常pHとしてはj〜りの範囲内tこて目的を達成するp
Hを選択すればよい。
Furthermore, during the reaction, an appropriate reaction medium such as dimethyl gluglulic acid-sodium hydroxide buffer, phosphate Mr# solution, Tris-clump acid buffer, boric acid M buffer, and other commonly used A Hi solution is used, and the pH is usually within the range of 1 to 2 to achieve the purpose.
Just select H.

例えは、0.3%のダーアミノアンチビリンなどの電子
受容体0.7〜0.2コ、0.2%のフェノールや!、
グージクロa7エ/−ルなどのフェノール系化合物0.
 / −0,2dの水素供与体、ペルオキシダーゼ5〜
20単位、リボオキシゲナーゼ10000〜30000
単位を含む0.7Mホワ酸緩衝液(pHL?0 )また
は02Mトリス−塩酸緩衝液/〜、2mlの組成を有す
る不飽和脂肪酸測定用組成物を調整する。次いで不飽和
脂肪酸全定量するtこ当って、−例を示せば、まず調整
した測定用組成物を被 37℃に予備加温し、これをこ不飽和脂肪酸含有阪検液
jOμLを加えて37℃でlO〜20分間反応せしめ1
反応終了後車色した度合を分光光度計1こて特異的吸収
波長1こて吸光度を測定する。そしてその吸光度から被
検液中の不飽和脂肪酸のjtを算出し、定量してなるも
のである。またリパーゼの 活性測定tだめの不飽和脂肪酸の定量としては、あらか
じめリパーゼ活性測定用基質?こりバーゼ活性を有する
被検液を作用せしめて遊離せしめた不飽和脂肪酸を定量
してもよく、また好ましくは前述の不飽和脂肪酸測定用
組成物にリパーゼ活性測定用基質を加えて調整した組成
物を用い℃、これ段 にリパーゼ活性測定用被検液を作用せしめて一般階1こ
て定量してなるものである。またリパーゼ活性測定にお
いて用いる基質としては、例えば0/M程度のグリセフ
ィトのエタノール溶eを調整し、これを組成物/〜2m
l当り20〜jOμを程度用いればよく、さらtここの
リパーゼ活性測定tこおいてはその組成物にデオキンコ
ール酸ナトリウムなどの界面活性剤を用いることが好ま
しい。
For example, 0.7 to 0.2 electron acceptors such as 0.3% deraminoantibilin, and 0.2% phenol! ,
Phenolic compounds such as goojichlor a7 el/- 0.
/ -0,2d hydrogen donor, peroxidase 5~
20 units, ribooxygenase 10,000-30,000
A composition for measuring unsaturated fatty acids having a composition of 2 ml of 0.7 M white acid buffer (pHL?0) or 02 M Tris-hydrochloric acid buffer containing the unit is prepared. Next, if you are unable to fully quantify the unsaturated fatty acids, for example, first preheat the prepared composition for measurement to 37°C, add jOμL of Saka test solution containing unsaturated fatty acids, and add 37°C. Incubate for 20 minutes at 10 °C.
After the reaction is completed, the degree of coloration is determined by measuring the absorbance using a spectrophotometer (1 trowel) and 1 specific absorption wavelength (1 trowel). From the absorbance, jt of unsaturated fatty acids in the test liquid is calculated and quantified. In addition, to quantify unsaturated fatty acids without measuring lipase activity, use a substrate for measuring lipase activity in advance. The unsaturated fatty acids liberated by the action of a test solution having koribase activity may be quantified, and preferably a composition prepared by adding a substrate for measuring lipase activity to the aforementioned composition for measuring unsaturated fatty acids. ℃, and a test solution for measuring lipase activity is applied to this stage, and the amount is determined using a general trowel. In addition, as a substrate used in lipase activity measurement, for example, prepare a solution of grisephyte in ethanol at a concentration of about 0/M, and add this to the composition/~2m
It is sufficient to use an amount of about 20 to JOμ per liter, and when measuring lipase activity, it is preferable to use a surfactant such as sodium dequincholate in the composition.

さらtこ本発明において、反応PH9時間、測定波長な
どについては、それぞれ使用する試薬によって異なるも
ので、適宜好適な条件を設定すればよい。
Furthermore, in the present invention, the reaction pH 9 time, measurement wavelength, etc. vary depending on the reagents used, and suitable conditions may be set as appropriate.

次1こ実施例を挙げて本発明を具体的に述べるが、本発
明はこれ1こよって何んら限定されるものではない。
The present invention will be described in detail with reference to the following example, but the present invention is not limited thereto in any way.

実施例1 O,/ Mホウ酸緩衝液(pH9,0)    0.2
d03%グーアミノアンチピリン    O5/102
%フェノール           0. / WLl
ペルオキシダーゼ(jO単位/、、)     0.2
dリボオキシゲナーゼ< soo、ooo単位/、)2
0μを蒸留水               0.3♂
1計/、 □ tgl 上記の組成を有する不飽和脂肪酸測定用組成物/、Od
を37℃に予備加温し、これに被検液として7mMリノ
ール酸含有エタノール溶液0〜jOuLまたは/mMリ
ルン酸含有エタノール溶液0〜jOμLを加えて37℃
で10分間反応せしめ、反応終了後蒸留水2−を加え、
その呈色を波長j 00 n m fCテ分光光度計で
吸光度(、ムA5oonm)を測定した。その結果、第
1図10示す通りで。
Example 1 O,/M borate buffer (pH 9,0) 0.2
d03% Guaminoantipyrine O5/102
%phenol 0. /WLl
Peroxidase (jO units/,,) 0.2
d-ribooxygenase < soo, ooo units/,)2
0μ distilled water 0.3♂
1 total/, □ tgl Composition for measuring unsaturated fatty acids having the above composition/, Od
was preheated to 37°C, and 0 to jOuL of a 7mM linoleic acid-containing ethanol solution or 0 to jOμL of a 7mM linoleic acid-containing ethanol solution was added thereto as a test solution, and the mixture was heated to 37°C.
After reaction for 10 minutes, add distilled water 2-
The absorbance of the color development was measured using a spectrophotometer at a wavelength of 00 nm. The result is as shown in Fig. 10.

図中・−・は被検液としてリノール酸を用いた場合の結
果を示し、〇−〇は被検液としてリルン酸を用いた場合
の結果を示すもので、極めて良好な定量結果を示したも
のであった。
In the figure, - indicates the results when linoleic acid was used as the test solution, and 〇-〇 indicates the results when linoleic acid was used as the test solution, which showed extremely good quantitative results. It was something.

実施例λ 0.2Mトリス−塩酸緩衝液(PHg、!; ) 0.
1m12%デオキンコール酸ナトリウム    Q、 
/ rRlo、/Mシリルツイン含有エタノール溶液 
 弘0μLリポオキシゲナーゼ(300pθθ単位/m
l)  60μtペルオキシダーゼ<so単位/、4)
   0,2wd!03%ダーアミノアンチピリン  
  Q、、2 m10.2%ノ、グージクロロフェノー
ル   0.21蒸留水              
  Oグ/m/計、2.0 at 上記の組成を含南する反応組成物2.0Tllfc37
℃tこ予備加温し、これeこ被検液として市販のリパー
ゼ試薬(クロモバクテリウム・ビスコサム由来の試薬:
東洋醸造社製)の0./U/Illのθ〜50μtを加
えて37℃で10分間反応せしめ1反応終了後その呈色
を波長50jnmkこよる分光光度計tごて吸光度(Δ
A 505nm ) t MIL定した。
Example λ 0.2M Tris-HCl buffer (PHg,!; ) 0.
1m 12% Sodium Deoquincholate Q,
/rRlo, /M silyl twin-containing ethanol solution
Hiro 0 μL lipoxygenase (300 pθθ units/m
l) 60 μt peroxidase <so units/, 4)
0.2wd! 03% Daraminoantipyrine
Q.2 ml 10.2% Goodichlorophenol 0.21 distilled water
Og/m/total, 2.0 at Reaction composition containing the above composition 2.0 Tllfc37
Prewarm it at ℃ and use a commercially available lipase reagent (reagent derived from Chromobacterium viscosum:
(manufactured by Toyo Jozo Co., Ltd.) 0. /U/Ill was added to θ ~ 50 μt and reacted at 37°C for 10 minutes. After one reaction, the color development was measured using a spectrophotometer with a wavelength of 50 nmk and the absorbance (Δ
A505nm) tMIL was determined.

その結果、第2図に示す通りで、極めて良好をこりパー
ゼ活性測定をなし得たものであった。
As a result, as shown in FIG. 2, extremely good results were obtained in the measurement of Koripase activity.

実施例3 0.2Mトリス−塩酸緩衝液(pHどo) o、gゴコ
%デオキンコール酸ナトリウム    0. / dO
,/ Mシリルツイン含有エタノール溶液  qoμt
リポオキシゲナーゼC300ρ00単位/I++7り5
0μtペルオキシダーゼ<SO単位7ml )    
 0.211L103%ダーアミノアンチピリン   
 Q、2JLt0.2%λ、ダージクロロフェノール 
  0.2Ll蒸留水               
O弘/at計2.0− 上記の組成を有する反応組成物2.0Nt37℃し に予備加温〜、これ1こ被検液として血清稀釈液508
m1加えて37℃、20分間反応せしめ、反応終了後そ
の呈色を波長60!;nmによる分光光度計にて吸光度
(ΔA505nm) を測定した。
Example 3 0.2M Tris-hydrochloric acid buffer (pH o) o, g Goco% sodium dequincholate 0. / dO
,/M silyl twin-containing ethanol solution qoμt
Lipoxygenase C300ρ00 units/I++7ri5
0μt peroxidase <SO unit 7ml)
0.211L 103% Daraminoantipyrine
Q, 2JLt0.2%λ, dichlorophenol
0.2Ll distilled water
Ohiro/at total 2.0 - 2.0 N of the reaction composition having the above composition, prewarmed to 37°C ~, 1 sample, serum diluted solution 508
ml was added and reacted at 37°C for 20 minutes, and after the reaction was completed, the color was measured at wavelength 60! Absorbance (ΔA505 nm) was measured using a spectrophotometer using nm.

その結果、第3図に示す通りで、極めて良好な定量結果
を得た。
As a result, as shown in FIG. 3, very good quantitative results were obtained.

東施例弘 実施例3と同一の組成を有する反応組成物2.01R1
’に37℃に予備加温し、これに血清稀釈液j0μを加
えて37℃にて反11cにせしめた。反応後5分経過後
から70分経過後の5分間の吸光度変化を波長JQ、f
nmlこて分光光度針にて測定した。
Reaction composition 2.01R1 having the same composition as Higashi Seikihiro Example 3
' was prewarmed to 37°C, and diluted serum j0μ was added thereto to make it diluted to 11c at 37°C. The change in absorbance for 5 minutes from 5 minutes after reaction to 70 minutes after reaction is measured at wavelength JQ, f
Measured using a nml trowel spectrophotometer needle.

その結果、第9図に示す通りであった。The results were as shown in FIG.

実施例5 実施例ダと同一の方法および公知の血清中リパーゼ活性
測定法(銅塩法+ CI in、 Chezr4 、.
2 /、 /ダ69〜/11.73C/り7j)〕にて
、血清中リパーゼ活性を37検体tこついて測定した。
Example 5 The same method as in Example D and the known method for measuring serum lipase activity (copper salt method + CI in, Chezr4, .
Serum lipase activity was measured in 37 samples at 2/, /Da69~/11.73C/Li7j)].

その結果両方法による相関を第5図にボすもので、その
相関係数はO9り761回帰式y= /、 2 f X
 十g、 6で、艮好な相関を示すものであった。
As a result, the correlation obtained by both methods is shown in Figure 5, and the correlation coefficient is given by the regression formula y= /, 2 f
10g and 6, showing a good correlation.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はリノール酸およびリルン酸の定量曲線を示し、
第2図はリパーゼ溶(&ヲ用いるリパーゼ活性測定曲線
を示し、第3図および第4図は血清中リパーゼ活性測定
曲線を示し、第5図は本発明方法と公知の銅塩法との相
関ケ示すものである。 特許出願人 東洋醸造株式益社 代表者 伊東冨士馬 第  /  図 H)  20 30 40 50.、】扱恢液(リノー
ル酸、リル/酸) 第2図 11J      20     30     40
     5+)1+1 9 ・・ −セ゛(、Hg  (0,+  LLz  
ml)第3図 血7#4釈1− 第  q  図 1川 (^ 召 釈 ・牟 手続補正書 7S事件の表示 昭和37年特許願第g390号 コ)発明の名称 新規な不飽和脂胞酸の定量法 3〜補正をする者 事件との関係 特許出願人 住所 静岡県田方郡大仁町三福632の/自  発 およびジグリセライド」を[モノグリセライドおよび/
、2ジグリセライド」と訂正する。 同第ワ頁第1/行の「3.s−キシレノールs N% 
N−ジ」を[3,5−キシレノール1アニリン系化合物
としてはN)N−ジ」と訂正する。
Figure 1 shows the quantitative curves of linoleic acid and linuric acid;
Figure 2 shows the lipase activity measurement curve using lipase solution (&), Figures 3 and 4 show the serum lipase activity measurement curve, and Figure 5 shows the correlation between the method of the present invention and the known copper salt method. Patent applicant: Toyo Jozo Co., Ltd. Representative: Fujima Ito / Figure H) 20 30 40 50. ] Treatment liquid (linoleic acid, lylu/acid) Fig. 2 11J 20 30 40
5+)1+1 9... -Se゛(,Hg (0,+LLz
ml) Figure 3 Blood 7 #4 Interpretation 1 - No. q Figure 1 River (^ Interpretation / Indication of Mutual Procedural Amendment 7S Case 1966 Patent Application No. G390 Co) Title of Invention Novel unsaturated fatty acid Quantification method 3 - Relationship with the case of the person making the amendment Patent applicant address 632 Mifuku, Ohito-cho, Tagata-gun, Shizuoka Prefecture
, 2 diglyceride,” he corrected. "3. s-xylenol s N%" on page 1, line 1 of the same page
"N-di" is corrected to "N)N-di" as a 3,5-xylenol-1 aniline compound.

Claims (1)

【特許請求の範囲】 (1)不飽和脂肪酸含有被検rttこ、酸素の存在下で
リボオキシゲナーゼを作用せしめて不飽和脂肪酸の過酸
化物となし、これにベルオキンダーゼおよび水素供与体
を作用せしめ、次いで反応系−こおける検出できる変化
を分光光学的手段tこ℃測定することを特徴とする不飽
和脂肪酸の定量法。 (2)不飽和脂肪酸含有被検液か、不飽和脂肪酸のグリ
セライドからリパーゼ活性をこまって遊離、生成した不
飽和脂肪酸を含有する被検液である特許請求の範囲第7
項記載の定量法。 (3)不飽和脂肪酸のグリセフィトが、不飽和脂肪酸の
モノグリセフィト、ジグリセライドまたはトリグリセフ
ィトである特許請求の範囲第2項記載の定量法。 (4)不飽和脂肪酸が、炭素数72〜20の不飽和脂肪
酸である特許請求の範囲第1項、第2項または第3頂層
社の定量法。 (5)炭素数72〜.20の不飽和脂肪酸が、2. ’
/’ −ドデカジエン酸、り/λ−ヘキサテ゛カシエン
酸。 す/−ル酸、リルン酸、乙9.lノーAクタテ゛カトリ
エン酸、/ /、 / +−エイコザンエン酸、左ざ。 l/−エイコサトリエン酸、gl/、/9−エイコサト
リエン酸またはアフキドン醒である特許請求の範囲第4
項記載の定量法。 (6)水素供与体が、呈色試薬%螢光試薬または光光試
薬である特許請求の範囲第/項記載の定量法(7)分光
光学的手段が、検出でさる変1ヒの特異的吸収波長をこ
よる分光光学的手段である特!l−l−請求の範囲第1
項記載の定−法。 (8)不飽和脂肪酸で6自仮検液が、リパーセ活性測定
用被@液である特許請求の範囲第7項または第2項記載
の定量法。
[Scope of Claims] (1) The unsaturated fatty acid-containing test rtt is treated with ribooxygenase in the presence of oxygen to form an unsaturated fatty acid peroxide, which is then treated with verokindase and a hydrogen donor, A method for quantifying unsaturated fatty acids, characterized in that a detectable change in the reaction system temperature is then measured by spectrophotometric means. (2) Claim 7, which is a test solution containing unsaturated fatty acids or a test solution containing unsaturated fatty acids released and produced from glycerides of unsaturated fatty acids through lipase activity.
Quantitative method described in section. (3) The assay method according to claim 2, wherein the unsaturated fatty acid glycephyte is an unsaturated fatty acid monoglycephyte, diglyceride, or triglycephyte. (4) The quantitative method of Claims 1, 2, or 3, wherein the unsaturated fatty acid is an unsaturated fatty acid having 72 to 20 carbon atoms. (5) Carbon number 72~. 20 unsaturated fatty acids, 2. '
/'-dodecadienoic acid, ri/λ-hexatecadienoic acid. 9. InoA catecatecatrienoic acid, / /, / +-eicozanenoic acid, left side. Claim 4 which is l/-eicosatrienoic acid, gl/, /9-eicosatrienoic acid or afquidone
Quantitative method described in section. (6) The quantitative method according to claim 1, wherein the hydrogen donor is a color-forming reagent, a fluorescent reagent, or a photoreagent. Special features that are spectroscopic optical means that determine the absorption wavelength! l-l-Claim 1
The law stated in the section. (8) The quantitative method according to claim 7 or 2, wherein the unsaturated fatty acid sample solution is a test solution for measuring lipase activity.
JP839082A 1982-01-21 1982-01-21 Novel method for determination of unsaturated fatty acid Pending JPS58126798A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP839082A JPS58126798A (en) 1982-01-21 1982-01-21 Novel method for determination of unsaturated fatty acid
FR8300685A FR2520006B1 (en) 1982-01-21 1983-01-18 METHOD FOR QUANTITATIVE MEASUREMENT OF UNSATURATED FATTY ACIDS
DE19833301655 DE3301655A1 (en) 1982-01-21 1983-01-19 Method for the quantitative determination of unsaturated fatty acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP839082A JPS58126798A (en) 1982-01-21 1982-01-21 Novel method for determination of unsaturated fatty acid

Publications (1)

Publication Number Publication Date
JPS58126798A true JPS58126798A (en) 1983-07-28

Family

ID=11691870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP839082A Pending JPS58126798A (en) 1982-01-21 1982-01-21 Novel method for determination of unsaturated fatty acid

Country Status (3)

Country Link
JP (1) JPS58126798A (en)
DE (1) DE3301655A1 (en)
FR (1) FR2520006B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5991898A (en) * 1982-11-19 1984-05-26 Toyo Jozo Co Ltd Composition for measuring activity of lipase
NL1007158C2 (en) * 1997-09-29 1999-03-30 Inst Voor Agrotech Onderzoek Enzymatic modification.
US20070122862A1 (en) * 2003-10-29 2007-05-31 Novozymes A/S Screening for lipolytic enzymes or amidase activity
WO2008014198A1 (en) * 2006-07-26 2008-01-31 Boehringer Ingelheim International Gmbh Lipoxygenase enzyme assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA763930B (en) * 1976-07-01 1978-02-22 Chembro Holdings Pty Ltd Determination of polyunsaturated fat levels in body fluids
US4347313A (en) * 1978-02-27 1982-08-31 Boehringer Mannheim Gmbh Analytical determination of lipase
JPS56117798A (en) * 1980-02-21 1981-09-16 Toyo Jozo Co Ltd Kit for measuring lipoid peroxide

Also Published As

Publication number Publication date
FR2520006A1 (en) 1983-07-22
DE3301655A1 (en) 1983-09-08
FR2520006B1 (en) 1986-07-25

Similar Documents

Publication Publication Date Title
Kurfürst et al. Characterization and postulated structure of the primary emitter in the bacterial luciferase reaction
JPS6221517B2 (en)
CN112044471B (en) Multifunctional nano enzyme, preparation method and application
US4369250A (en) Fatty acid determination
Gutteridge et al. The thiobarbituric acid-reactivity of bile pigments
US4367285A (en) Assaying lipid peroxide in lipid compositions
JPS5850719B2 (en) How to quantify triglycerides
Pastor et al. A ready-to-use fluorimetric biosensor for superoxide radical using superoxide dismutase and peroxidase immobilized in sol–gel glasses
JPH06505627A (en) Analysis method
JPS58126798A (en) Novel method for determination of unsaturated fatty acid
Kurooka et al. Properties of serum lipase in patients with various pancreatic diseases analysis by a new serum lipase assay method (The BALB-DTNB Method) in combination with gel-filtration and iso-electrofocusing techniques
CN109283161B (en) Method for detecting peroxide value in grease by using fluorescence quenching method
Liu et al. Visualization of peroxidase isozymes with eugenol, a noncarcinogenic substrate
JPS59183698A (en) Quantitative determination of substrate
US5202233A (en) Process for the detection of substances with hydrolase activity
JP3359822B2 (en) Highly sensitive substance measurement method
JP3071852B2 (en) Pancreatic lipase measurement reagent
JPH0650299B2 (en) Salicylate detection method
JPS58187858A (en) Stabilization of oxidation-receiving color identification reagent
CA1202869A (en) Method for the quantitative measurement of the phosphatidyl glycerol
CN105164273B (en) The assay method of mankind&#39;s pancreatic lipase activity
RU2700708C1 (en) Method for separate determination of organic and inorganic hydroperoxides by chemiluminescence using catalase
Negrin Measurement of Cholesterol in Tissues with Phospho-6-tungstic-12-molybdic Acid
JP3359821B2 (en) Quick method for measuring substances
JPS5876100A (en) Use of laccase